IP Library Granted Patent US 10,814,327
Granted Patent B2
US 10,814,327 · App. 15/646,578 · Granted Oct 27, 2020

Assay cartridges and methods of using the same

Inventors: Eli N. Glezer (Del Mar, CA); Stephen Higgins (Geithersburg, MD); Sandor Kovacs (Middletown, DE); Sudeep Kumar (Gatihersburg, MD); Kenneth Page (Germantown, MD); Kristian Roth (Germantown, MD); George Sigal (Rockville, MD)
Assignee: MESO SCALE TECHNOLOGIES, LLC.
B01L7/525B01L3/5027B01L2200/027B01L2200/0605B01L2200/0621B01L2200/0631B01L2200/10B01L2200/146B01L2200/16B01L2300/0645B01L2300/087B01L2300/0816B01L2300/0864B01L2300/0867B01L2300/0883B01L2400/0487B01L2400/0688B01L2400/0694C12Q1/686
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,814,327
App. No.
15/646,578
Granted
Oct 27, 2020
Kind
B2
Abstract

Assay cartridges are described that have purification, reaction, and detection zones and other fluidic components which can include sample chambers, waste chambers, conduits, vents, reagent chambers, reconstitution chambers and the like. The assay cartridges are used to conduct multiplexed nucleic acid measurements. Also described are kits including such cartridges, methods of using the same, and a reader configured to analyze an assay conducted using an assay cartridge.

Claims (23)

1. A fluidic network comprising a chamber connected to an air vent port, said fluidic network comprising:

a primary flow path comprising a purification zone; and

one or more fluidic conduits each intersecting said primary flow path and fluidically connecting said primary flow path to said chamber, wherein said fluidic network is configured to meter a volume of fluid in said network, wherein said fluidic network is configured to meter a volume of fluid in said network between a first temperature controlled zone and a second temperature controlled zone, wherein a temperature of the first temperature controlled zone is different from a temperature of the second temperature controlled zone.

2. The fluidic network of claim 1 , wherein a fluidic conduit of said one or more fluidic conduits comprises a multi-conduit fluidic junction including (i) a first conduit connecting said primary flow path and said chamber, and (ii) a second conduit connecting said chamber to said air vent port, wherein said fluidic conduit is in communication with an optical fluid sensor at a position distal from said fluidic junction and said metered volume of fluid is defined by the distance between said fluidic junction and said distal position.

3. The fluidic network of claim 2 , wherein said multi-conduit fluidic junction is a three-way junction.

4. A system configured to interface with a fluidic network of claim 1 , said system comprising a fluidic control manifold configured to drive fluid motion within said fluidic network, wherein the fluidic control manifold comprises at least two types of valves between the fluidic network and the system.

5. The system of claim 4 wherein said fluidic control manifold comprises a pump and a pressure sensor and said system is configured to align said fluidic control manifold with one or more air vent ports positioned in said fluidic network.

6. The fluidic network of claim 1 , wherein the chamber comprises a dried reagent that can be rehydrated by said metered volume of fluid.

7. The fluidic network of claim 6 , wherein the dried reagent s in the form of a dry pill.

8. The fluidic network of claim 7 , wherein the chamber comprises a fluid inlet at a bottom of the chamber, wherein the air vent is at a top of the chamber.

9. The fluidic network of claim 8 , wherein the pill is in the chamber between the fluid inlet and the air vent port.

10. The fluidic network of claim 9 , wherein a fluid path is provided in the chamber, around the pill.

11. The fluidic network of claim 9 , wherein the pill is retained in the chamber by a cradle of sloping brackets extending from an interior of the chamber.

12. The fluidic network of claim 9 , wherein walls of the chamber do not conform with the pill.

13. The fluidic network of claim 9 , wherein the chamber comprises lobes that are not in contact with the pill.

14. The fluidic network of claim 7 , wherein the chamber further comprises a boundary surface.

15. The fluidic network of claim 14 , wherein the boundary surface is raised as compared to a bottom surface of the chamber.

16. The fluidic network of claim 15 , wherein the boundary surface is raised by 0.5 μm to 200 μm above the bottom surface of the chamber.

17. The fluidic network of claim 14 , wherein the boundary surface is more hydrophobic as compared to a bottom surface of the chamber.

18. The fluidic network of claim 14 , wherein the boundary surface comprises a sharply defined edge between the boundary surface and a bottom surface of the chamber.

19. The fluidic network of claim 18 , wherein the boundary surface comprises a contact angle for water of at least ten degrees less than the boundary surface.

20. The system of claim 4 , wherein the at least two types of valves are selected from a rotary shear valve and a solenoid relief valve.

21. The fluidic network of claim 1 , wherein the primary flow path comprises, from a proximal to a distal end, an inlet, the purification zone, a reaction zone, and a detection zone, wherein said primary flow path further comprises one or more of said air vent ports.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 26, 2023
From: MESO SCALE DIAGNOSTICS, LLC
To: UNITED STATES GOVERNMENT
Reel/Frame 064104/0911 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2020
From: GLEZER, ELI N.; HIGGINS, STEPHEN; KOVACS, SANDOR; KUMAR, SUDEEP; PAGE, KENNETH; ROTH, KRISTIAN; SIGAL, GEORGE
To: MESO SCALE TECHNOLOGIES, LLC.
Reel/Frame 053826/0821 →
Continuity (3)
Continuation 13343834 · Jan 5, 2012
Provisional Application 61460708 · Jan 6, 2011
Related Publication 20170312751A1 · Nov 2, 2017